Result of 2022 Annual General Meeting

RNS Number : 1694L
Impact Healthcare REIT PLC
11 May 2022
 

11 May 2022

Impact Healthcare REIT plc

("Impact" or the "Company")

Result of 2022 Annual General Meeting

The Board of Impact Healthcare REIT plc (ticker: IHR), the real estate investment trust which gives investors exposure to a diversified portfolio of UK healthcare real estate assets, in particular care homes, announces that at the Company's 2022 Annual General Meeting held today, all resolutions proposed at the AGM were voted on and passed by a poll by the Company's shareholders and the results of the poll, including the proxy votes received, are set out below.

 

Resolutions 1 to 13 (inclusive) were proposed as ordinary resolutions and resolutions 14 to 17 (inclusive) were proposed as special resolutions.

 


Resolution

Votes For*

%

Votes Against

%

Total votes validly cast

Total votes cast as % of issued share capital

Votes Withheld **

1

Receive the Annual Report and Financial Statements Year 31 December 2021

251,573,238

100.00

7,221

0.00

251,580,459

65.22

59,516

2

Approve the directors' remuneration report

251,323,630

99.92

209,371

0.08

251,533,001

65.21

106,974

3

Approve the Company's Dividend Policy

251,628,018

100.00

7,284

0.00

251,635,302

65.24

4,673

4

Re-elect Rupert Barclay as a director

230,507,309

91.60

21,126,208

8.42

251,633,517

65.24

6,458

5

Re-elect Rosemary Boot as a director

250,763,972

99.65

875,126

0.35

251,639,098

65.24

877

6

Re-elect Philip Hall as a director

250,784,041

99.66

855,057

0.34

251,639,098

65.24

877

7

Re-elect Amanda Aldridge as a director

250,592,707

99.59

1,043,896

0.42

251,636,603

65.24

3,372

8

Re-elect Paul Craig as a director

251,441,260

99.92

197,838

0.08

251,639,098

65.24

877

9

Elect Chris Santer as a director

250,778,612

99.66

854,905

0.34

251,633,517

65.24

6,458

10

To re-appoint BDO LLP as the Company's auditor

246,553,042

99.97

82,684

0.03

246,635,726

63.94

5,004,249

11

To authorise the board of directors to determine the auditors remuneration

251,629,319

100.00

7,284

0.00

251,636,603

65.24

3,372

12

To authorise the Directors to allot shares under section 551 Companies Act 2006

251,611,445

99.99

14,388

0.01

251,625,833

65.23

14,142

13

Subject to the passing of resolution 12, to authorise the Directors to allot additional shares under section 551 Companies Act 2006

251,611,445

99.99

19,969

0.01

251,631,414

65.23

8,561

14

Subject to the passing of resolution 12, to disapply statutory pre-emption rights under section 570 Companies Act 2006

251,282,594

99.86

347,943

0.14

251,630,537

65.23

9,438

15

Subject to the passing of resolution 13, to disapply statutory pre-emption rights under section 570 Companies Act 2006

243,834,977

96.90

7,796,437

3.11

251,631,414

65.23

8,561

16

To authorise the Company to make market purchase of its own ordinary shares

245,402,154

97.54

6,191,222

2.47

251,593,376

65.22

46,599

17

To permit general meetings to be called on 14 days' notice

248,281,004

98.67

3,344,829

1.33

251,625,833

65.23

14,142

 

Every shareholder has one vote for every Ordinary Share held. As at close of business on 11 May 2022, the share capital of the Company consisted of 385,731,908 Ordinary Shares with voting rights. The Company does not hold any shares in Treasury.

 

In accordance with Listing Rule 9.6.2, copies of all the resolutions passed, other than ordinary business, will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

 

* Includes discretionary votes.

** A vote withheld is not a vote in law and is not counted in the calculation of the votes for or against a resolution.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Impact Health Partners LLP

Mahesh Patel

Andrew Cowley

via Maitland/AMO



JTC (UK) Limited - Company Secretary

Christopher Gibbons

0203 846 9774

Impact.CoSec@jtcgroup.com

 


Maitland/AMO (Communications Adviser)

James Benjamin

07747 113 930

i mpact health-maitland@maitland.co.uk

 

The Company's LEI is 213800AX3FHPMJL4IJ53.

 

NOTES

Impact Healthcare REIT plc acquires, renovates, extends and redevelops high quality healthcare real estate assets in the UK and lets these assets on long-term full repairing and insuring leases to high-quality established healthcare operators which offer good quality care, under leases which provide the Company with attractive levels of rent cover .

 

The Company aims to provide shareholders with an attractive sustainable return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified and resilient portfolio of UK healthcare real estate assets, in particular care homes for the elderly.

 

The Company has a progressive dividend policy with a target to grow its annual aggregate dividend in line with the inflation-linked rental uplifts received by the Group under the terms of the rent review provisions contained in the Group's leases in the prior financial year.

 

On this basis, the target total dividend for the year ending 31 December 2022 is 6.54 pence per share 1 , a 2.0% increase over the 6.41 pence in dividends paid or declared per ordinary share for the year ended 31 December 2021.

 

The Group's Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, premium segment, on 8 February 2019. The Company is a constituent of the FTSE EPRA/NAREIT index.

 

1  This is a target only and not a profit forecast. There can be no assurance that the target will be met and it should not be taken as an indicator of the Company's expected or actual results.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGFLFIRELILLIF
UK 100

Latest directors dealings